AnaptysBio, Inc.

ANAB

NASDAQ

Healthcare

Biotechnology

San Diego, CA, US136 employeesanaptysbio.com

$57.98

+1.25(2.20%)

Mkt Cap $1.7B

$16.24

$67.29

52-Week Range

At a Glance

AI-generated

Revenue breakdown: Anaptys Bio Generated Anti PD1Jemperli Dostarlimab (99.1%), License (0.9%), Transaction Service (0%).

8-K

AnaptysBio, Inc. announced the spin-off of its subsidiary First Tracks Biotherapeutics, which will become an independent public company. The spin-off includes a private placement for First Tracks, the termination of an existing sales agreement, executive transitions, and a new stock repurchase plan for AnaptysBio.

$1.7B

Market Cap

$243M

Revenue

-$14M

Net Income

Employees136

Fundamentals

How The Business Makes Money

Revenue by Segment

Anaptys Bio Generated Anti PD1Jemperli Dostarlimab99.1%($1.0B)

License0.9%($10M)

Transaction Service0%($200.0K)

Activity

What Changed Recently

Financial Results

Mar 2, 2026

and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document filed by AnaptysBio with the Secur

Financial Results

Jan 8, 2026

shall not be incorporated by reference into any registration statement or other document filed by AnaptysBio with the Securities and Exchange Commission, whethe

Management Change+3 More

Mar 26, 2026

Entry into a Material Definitive Agreement. On March 26, 2026, First Tracks Biotherapeutics and EcoR1 Capital Fund Qualified, L.P. (the “Selling Stockholder”) e

Peer Companies

Company	Price	Change	Market Cap	P/E
DNTHDianthus Therapeutics, In...	$86.51	+2.31%	$3.3B	—
KODKodiak Sciences Inc.	$40.55	-5.28%	$2.1B	-5.4
MNMDMind Medicine (MindMed) I...	$20.65	+0.24%	$1.6B	-8.8
OCSOculis Holding AG	$26.48	-2.03%	$1.5B	-11.0
NRIXNurix Therapeutics, Inc.	$15.51	+0.16%	$1.3B	-5.3
TSHATaysha Gene Therapies, In...	$4.38	+1.74%	$1.1B	-13.3
XNCRXencor, Inc.	$12.79	+2.11%	$938M	-9.7
URGNUroGen Pharma Ltd.	$18.84	-0.53%	$917M	-5.5

Analyst View

Company Profile

CIK0001370053

ISINUS0327241065

CUSIP032724106

Phone858 362 6295

Address10770 Wateridge Circle, San Diego, CA, 92121-5801, US

SEC EDGAR